IT1290828B1 - Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche - Google Patents

Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Info

Publication number
IT1290828B1
IT1290828B1 IT97MI000694A ITMI970694A IT1290828B1 IT 1290828 B1 IT1290828 B1 IT 1290828B1 IT 97MI000694 A IT97MI000694 A IT 97MI000694A IT MI970694 A ITMI970694 A IT MI970694A IT 1290828 B1 IT1290828 B1 IT 1290828B1
Authority
IT
Italy
Prior art keywords
medications
preparation
treatment
pathological conditions
animal organs
Prior art date
Application number
IT97MI000694A
Other languages
English (en)
Inventor
Alberto Panerai
Pier Luigi Meroni
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT97MI000694A priority Critical patent/IT1290828B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Priority to CA002284548A priority patent/CA2284548A1/en
Priority to BR9808625-1A priority patent/BR9808625A/pt
Priority to IL13201398A priority patent/IL132013A0/xx
Priority to AU72072/98A priority patent/AU7207298A/en
Priority to JP54483098A priority patent/JP2001518107A/ja
Priority to TR1999/02331T priority patent/TR199902331T2/xx
Priority to EP98919103A priority patent/EP0969859A1/en
Priority to US09/381,737 priority patent/US6255283B1/en
Priority to NZ337985A priority patent/NZ337985A/en
Priority to HU0002304A priority patent/HUP0002304A3/hu
Priority to CN98803626A priority patent/CN1251043A/zh
Priority to KR1019997008773A priority patent/KR20010005705A/ko
Priority to PL98335829A priority patent/PL335829A1/xx
Priority to PCT/EP1998/001516 priority patent/WO1998042366A1/en
Publication of ITMI970694A1 publication Critical patent/ITMI970694A1/it
Application granted granted Critical
Publication of IT1290828B1 publication Critical patent/IT1290828B1/it
Priority to NO994622A priority patent/NO994622D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IT97MI000694A 1997-03-25 1997-03-25 Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche IT1290828B1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT97MI000694A IT1290828B1 (it) 1997-03-25 1997-03-25 Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
HU0002304A HUP0002304A3 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
IL13201398A IL132013A0 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
AU72072/98A AU7207298A (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
JP54483098A JP2001518107A (ja) 1997-03-25 1998-03-16 腫瘍壊死因子（ｔｎｆ）の過剰産生により特徴づけられる病的状態の処置のための医薬を調製するための動物器官から抽出可能なタンパク質類の使用
TR1999/02331T TR199902331T2 (xx) 1997-03-25 1998-03-16 T�m�r nekroz fakt�r�n�n (TNF) hiper-�retimi ile vas�flanan patolojik ko�ullar�n iyile�tirilmesi i�in t�bbi maddelerin haz�rlanmas� i�in hayvan organlar�ndan ekstre edilebilen proteinlerin kullan�m�.
EP98919103A EP0969859A1 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
US09/381,737 US6255283B1 (en) 1997-03-25 1998-03-16 Use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF)
CA002284548A CA2284548A1 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
BR9808625-1A BR9808625A (pt) 1997-03-25 1998-03-16 O uso de proteìnas extraìveis de órgãos de animal para a preparação de medicamentos para o tratamento de condições patológicas caracterizadas por hiperprodução de fator de necrose de tumor (tnf)
CN98803626A CN1251043A (zh) 1997-03-25 1998-03-16 可从动物器官中提取的蛋白质在制备可用于治疗疾病的药物中的用途
KR1019997008773A KR20010005705A (ko) 1997-03-25 1998-03-16 동물의 장기로부터 추출가능한 단백질을 이용하여 종양괴사인자 (ｔｎｆ)를 과잉생산하는 특성을 나타내는 질병 치료용 약물을 제조하는 방법
PL98335829A PL335829A1 (en) 1997-03-25 1998-03-16 Application of proteins extracted from animal body organs for preparation of medicines useful in treatment of pathogenic states characterised by overproduction of tumour necrosis factor (thf)
PCT/EP1998/001516 WO1998042366A1 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
NZ337985A NZ337985A (en) 1997-03-25 1998-03-16 The use of proteins extracted from mammal liver for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF)
NO994622A NO994622D0 (no) 1997-03-25 1999-09-23 Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000694A IT1290828B1 (it) 1997-03-25 1997-03-25 Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Publications (2)

Publication Number Publication Date
ITMI970694A1 ITMI970694A1 (it) 1998-09-25
IT1290828B1 true IT1290828B1 (it) 1998-12-11

Family

ID=11376611

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI000694A IT1290828B1 (it) 1997-03-25 1997-03-25 Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Country Status (16)

Country Link
US (1) US6255283B1 (it)
EP (1) EP0969859A1 (it)
JP (1) JP2001518107A (it)
KR (1) KR20010005705A (it)
CN (1) CN1251043A (it)
AU (1) AU7207298A (it)
BR (1) BR9808625A (it)
CA (1) CA2284548A1 (it)
HU (1) HUP0002304A3 (it)
IL (1) IL132013A0 (it)
IT (1) IT1290828B1 (it)
NO (1) NO994622D0 (it)
NZ (1) NZ337985A (it)
PL (1) PL335829A1 (it)
TR (1) TR199902331T2 (it)
WO (1) WO1998042366A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
US20030162704A1 (en) * 2000-06-08 2003-08-28 Alberto Panerai Method of treatment of parkison's disease with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US6855694B2 (en) 2000-06-08 2005-02-15 Rakepoll Holding B.V. Method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20021205A1 (it) * 2002-06-04 2003-12-04 Pharmaproducts Uk Ltd Uso di proteine per il trattamento della leishmaniosi
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
FR2688227A1 (fr) * 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
GB9419553D0 (en) 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
KR20000036207A (ko) 1996-09-18 2000-06-26 스피니엘로 살바토르 자가면역 질환 치료제로서의 단백질의 용도
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins

Also Published As

Publication number Publication date
NO994622L (no) 1999-09-23
CN1251043A (zh) 2000-04-19
TR199902331T2 (xx) 2000-01-21
US6255283B1 (en) 2001-07-03
CA2284548A1 (en) 1998-10-01
AU7207298A (en) 1998-10-20
HUP0002304A3 (en) 2001-12-28
NO994622D0 (no) 1999-09-23
IL132013A0 (en) 2001-03-19
WO1998042366A1 (en) 1998-10-01
JP2001518107A (ja) 2001-10-09
NZ337985A (en) 2001-02-23
BR9808625A (pt) 2000-05-16
KR20010005705A (ko) 2001-01-15
EP0969859A1 (en) 2000-01-12
ITMI970694A1 (it) 1998-09-25
HUP0002304A2 (hu) 2000-11-28
PL335829A1 (en) 2000-05-22

Similar Documents

Publication Publication Date Title
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
EE9900469A (et) Sulfoonamiidid endoteliini vahendatud haiguste raviks
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
ATE225949T1 (de) Motorgesteuertes chirurgisches system
DE69839989D1 (de) Bildgesteuertes chirurgisches system
DE69833881D1 (de) Chirurigisches positioniersystem
DE59709443D1 (de) Blutpumpe
DE69837924D1 (de) Chromophoren zur herstellung von neuen tandem-konjugaten
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
DE69939068D1 (de) Entfernbare implantierbare medizinische leitung
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
IT1290828B1 (it) Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE29700307U1 (de) Zerstäuber für medizinische Zwecke
MA26801A1 (fr) Complexe pharmaceutique
DE29715168U1 (de) Chirurgisches Endoskop
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
ES1032126Y (es) Juego esterilizable para la autoinyeccion de drogas.
ITMI940414A0 (it) Procedimento per la coniugazione di proteine di interesse terapeutico o diagnostico
IT1298437B1 (it) Procedimento per la produzione di proteine/peptidi tossici
ITMI941465A0 (it) Proteine ad attivita' antitumorale da organi di mammiferi
DE29820295U1 (de) Modulares augenärztliches Untersuchungssystem

Legal Events

Date Code Title Description
0001 Granted